| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ORGE
|
21.62 | 1.7B | 2.26 | 0.38 | 1.26 | 34.5% | 45.6% | 76 | 51 | 46.45 | +86.1% | 93 | 0.03 |
|
CWENE
|
30.78 | 33.2B | 15.47 | 2.06 | 9.18 | 5.1% | 37.8% | 51 | 26 | 28.02 | -6.0% | 51 | 0.56 |
|
YEOTK
|
31.98 | 26.5B | 16.33 | 5.83 | 10.41 | 22.6% | 35.4% | 50 | 35 | 26.04 | -12.5% | 48 | 1.80 |
|
SAYAS
|
53.75 | 4.2B | 18.60 | 3.02 | 10.38 | 14.9% | 42.6% | 48 | 25 | 35.54 | -25.4% | 85 | 0.26 |
|
SMRTG
|
9.00 | 16.4B | — | 3.23 | 7.31 | 5.8% | 32.4% | 46 | 36 | 11.52 | +14.3% | 27 | 2.26 |
|
EKOS
|
4.70 | 5.3B | — | 1.59 | — | -2.5% | 44.1% | 42 | 29 | 7.41 | +24.9% | 58 | 0.22 |
|
ALFAS
|
37.80 | 13.9B | 100.00 | 2.37 | 18.47 | 1.8% | 38.2% | 33 | 19 | 16.78 | -37.3% | 48 | 0.55 |
|
ASTOR
|
293.50 | 292.9B | 34.96 | 7.63 | 27.81 | 15.5% | 42.7% | 33 | 16 | 114.59 | -45.7% | 86 | 0.17 |
|
GESAN
|
67.20 | 30.9B | 34.14 | 2.02 | 13.31 | 13.1% | 38.5% | 33 | 28 | 42.51 | -26.5% | 69 | 0.33 |
|
BRLSM
|
19.53 | 4.4B | — | 2.71 | 13.26 | 6.6% | 42.9% | 32 | 36 | 15.82 | -9.7% | 34 | 0.66 |
|
EUPWR
|
74.85 | 49.4B | 60.18 | 4.06 | 21.40 | 13.9% | 42.0% | 30 | 22 | 30.70 | -44.2% | 77 | 0.24 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.